Search all trials

Find therapies in clinical trials near you – page 5

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Breast cancer+3

Not recruiting

Registered drug

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Capivasertib

Contact Research Centre

Dermatitis atopic

Not recruiting

Registered drug

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Registered drug

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Lebrikizumab

Contact Research Centre

Hormone receptor positive HER2 negative breast cancer

Not recruiting

Registered drugNo placebo

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anastrozole

Contact Research Centre

Non-small cell lung cancer stage III

Not recruiting

Registered drugNo placebo

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

HER2 positive breast cancer

Not recruiting

Registered drugNo placebo

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Trastuzumab Deruxtecan

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Vemurafenib

Contact Research Centre

Diffuse large B-cell lymphoma refractory

Not recruiting

Registered drug

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Brentuximab Vedotin

Contact Research Centre

Breast cancer metastatic

Not recruiting

Registered drugNo placebo

Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Carboplatin

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Not recruiting

Registered drugNo placebo

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Oseltamivir

Contact Research Centre

Plasma cell myeloma

Not recruiting

Registered drugNo placebo

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Registered drugNo placebo

France

Participants:65+ years
Substances:Bortezomib

Contact Research Centre

Acute kidney injury

Not recruiting

Registered drug

Study on the Effects of Irbesartan After Acute Kidney Injury in Patients Discharged from ICU

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Irbesartan

Contact Research Centre

Find therapies in clinical trials near you – page 5

62 trials match your criteria

Breast cancer+3

Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

Dermatitis atopic

Study on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis

Hormone receptor positive HER2 negative breast cancer

Study of palbociclib with hormone therapy guided by ESR1 mutation monitoring in patients with ER-positive, HER2-negative metastatic breast cancer

Non-small cell lung cancer stage III

Study of Atezolizumab and Tiragolumab Compared to Durvalumab for Patients with Advanced Non-Small Cell Lung Cancer After Chemoradiation

HER2 positive breast cancer

Study Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with High-Risk HER2-Positive Breast Cancer with Residual Disease After Initial Treatment

Neoplasm

Study on Vemurafenib for Patients with Advanced Cancers with BRAF Gene Changes

Diffuse large B-cell lymphoma refractory

Study on Brentuximab Vedotin, Lenalidomide, and Rituximab for Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma

Breast cancer metastatic

Study Comparing Olaparib and Pembrolizumab with Chemotherapy and Pembrolizumab for Patients with Advanced Triple-Negative Breast Cancer

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Study of oseltamivir and paracetamol blood levels in critically ill patients with severe influenza requiring mechanical ventilation

Plasma cell myeloma

Study on Isatuximab, Lenalidomide, and Dexamethasone for Elderly Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Acute kidney injury

Study on the Effects of Irbesartan After Acute Kidney Injury in Patients Discharged from ICU

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.